Open Site Navigation

Future Drug Targets in Periodontal Personalized Medicine—A Narrative Review

Periodontal diseases consist of a cluster of pathological conditions initiated by a complex microbial community causing inflammation within the supporting tissues of the teeth leading to attachment and tooth loss. Severe periodontitis is one of the leading causes 2 of 14 of tooth loss worldwide. Periodontitis is thought to affect 20–50% of the world’s population and is the 11th most prevalent disease globally. The main etiology of periodontal diseases can be attributed to bacterial biofilm. Several hosts and environmental factors such as genetic predisposition, lifestyle, oral hygiene, systemic conditions, and stress contribute to the onset and progression of periodontitis.


Yadalam_Patil_J of Personalized Medecine 2022
.pdf
Download PDF • 344KB

©2022 by Direct Diagnostics LLC. Direct Diagnostics is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, and meets the requirements to perform high complexity tests. CLIA Registration 45D2190910. 

Direct Diagnostics is certified under the College of American Pathologists (CAP), CAP Accreditation #9088531

Website by Redwood Designs.

  • Instagram
  • LinkedIn | Direct Dx
  • Facebook
  • YouTube